Typhoid Fever

Introduction

Typhoid fever, also known as enteric fever, is a potentially fatal illness caused by the bacterium Salmonella Typhi. For centuries, typhoid fever was a widely feared disease that caused frequent outbreaks with high death rates. While typhoid has become rare in industrialized nations, it continues to be a serious public health issue in developing countries. An estimated 11-20 million cases still occur worldwide each year. Understanding the symptoms, causes, risk factors and advances in diagnosis and treatment of typhoid is key for proper prevention and care.

Symptoms

The symptoms of typhoid fever are variable but most commonly include,

• Sustained high fever over 103°f (39.4°c)
• Intense headache
• Nausea
• Abdominal pain
• Diarrhea or constipation
• Loss of appetite.

Some patients also develop a flat, rose-colored rash on the trunk area. Symptoms generally come on gradually, starting 1-3 weeks after exposure to the bacteria. Without treatment, symptoms can persist for weeks or months, with the risk of serious complications rising the longer the infection goes untreated.

Causes and Transmission

Typhoid fever is caused by the bacteria Salmonella enterica serotype Typhi. It is primarily transmitted through ingestion of food or water that has been contaminated with the feces of an infected person. Contamination often occurs when infected people do not wash their hands properly after defecating and then handle food products. Once ingested, the bacteria spread into the bloodstream where they multiply rapidly, resulting in the signs and symptoms of typhoid. Less commonly, the disease can be acquired through direct contact with contaminated body fluids of infected individuals.

Risk Factors

Typhoid has the greatest impact in resource-limited areas with poor sanitation and limited access to clean water. Therefore, the highest risk areas are South Asia, Southeast Asia and sub-Saharan Africa. Within endemic regions, children are at greatest risk due to weaker immune systems and lack of previous exposure. Travelers to endemic zones are also at increased risk if consuming local foods and beverages. Typhoid outbreaks continue to occur sporadically in isolated communities such as refugee camps, prisons or rural towns with contaminated water supplies. Even extremely careful food preparation does not eliminate Salmonella Typhi.

Complications

Serious complications can occur without prompt antibiotic treatment of typhoid. Intestinal bleeding or perforation of the intestine can be fatal. Bacteria may also spread into the bloodstream and infect other organs like the heart, potentially causing endocarditis (infection of heart valves) or meningitis (infection of membranes surrounding the brain). Severe typhoid can also lead to delirium, stupor or coma. The overall fatality rate for untreated typhoid is 10-30%, but approaches just 1-4% for appropriately treated patients. Relapse of typhoid fever can occur in roughly 10% of adequately treated cases. A small proportion individuals who recover continue shedding bacteria for months or years as chronic carriers.

Diagnosis

Isolation of Salmonella Typhi from blood, bone marrow or stool culture provides a definitive diagnosis. However, diagnosis is often presumptive based on consistent clinical findings, especially in endemic regions with limited access to bacterial cultures. Newer rapid antibody-based tests show promise for improved access to confirm typhoid in remote settings. Analysis of the antibody response can also classify individuals as having acute, recovering/resolved or chronic carrier state infections.

Treatment

Typhoid fever was formerly treated primarily through supportive care rather than specific therapy for the underlying infection. The introduction of chloramphenicol antibiotics in 1948 dramatically reduced mortality. Over time antibiotic resistance became widespread, driving shifts to alternative agents like ampicillin, co-trimoxazole and fluoroquinolones. Unfortunately, due to ongoing evolution of chromosomally-encoded resistance mechanisms, bacterial strains with reduced susceptibility to these second line medications have also emerged. This underscores the vital need for new antibiotics to battle typhoid. The UK-based company Novophage recently reported positive Phase 2 results for a novel bacteriophage therapy targeting Salmonella Typhi. While antibiotics remain the mainstream treatment, phage therapy offers an exciting potential addition to the anti-typhoid arsenal.

Prevention

In regions where typhoid is endemic, prevention centers around public health measures to improve sanitation and access to clean drinking water. Health departments try to rapidly detect new outbreaks, treating cases and carriers, while tracing contacts and contaminated food or water sources. Both oral and injectable typhoid vaccines help reduce disease incidence in high risk areas. Researchers work to develop more effective and longer lasting vaccine options, including a new conjugate vaccine administered to infants and children. Counseling travelers to endemic regions on safe food and water precautions also prevents a substantial number of typhoid cases. Implementing these layered prevention strategies in tandem with prompt diagnosis and antibiotic treatment provides the optimal approach to combating this persistent threat. Despite the challenges ahead, the fight against typhoid continues to make strides through practical public health measures coupled with scientific and medical advances.